Bryan M. Reasons Aclaris Therapeutics, Inc. (ACRS) insider trading activity

ACRS Quotes by TradingView

Bryan M. Reasons is of Aclaris Therapeutics, Inc.. Currently has a direct ownership of 28,732 shares of ACRS, which is worth approximately $60,049. The most recent transaction as insider was on Jun 01, 2024, when has been sold 4,660 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.7K
0% 3M change
19.36% 12M change
Total Value Held $60,049

Bryan M. Reasons Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 01 2024
BUY
Exercise of conversion of derivative security
-
4,660 Added 13.96%
28,732 Common Stock
Jun 02 2023
BUY
Exercise of conversion of derivative security
-
4,507 Added 15.77%
24,072 Common Stock
Jun 03 2022
BUY
Exercise of conversion of derivative security
-
3,356 Added 14.64%
19,565 Common Stock

Also insider at

MNKPF
Mallinckrodt plc Healthcare
EVP & CFO
REPH
Societal CDMO, Inc. Healthcare
Director
BMR

Bryan M. Reasons

Wayne, PA

Track Institutional and Insider Activities on ACRS

Follow Aclaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRS shares.

Notify only if

Insider Trading

Get notified when an Aclaris Therapeutics, Inc. insider buys or sells ACRS shares.

Notify only if

News

Receive news related to Aclaris Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ACRS